Symbols

MTEM(Delisted)

Molecular Templates·NASDAQ

--(--)

MTEM fundamentals

MTEM Q4 undefined Earnings

Molecular Templates (MTEM) released its earnings on Mar 28, 2018: revenue was -- (YoY --), beat estimates; EPS was -- (YoY --), met estimates.

Revenue / YoY

EPS / YoY

Report date

Mar 28, 2018

Earnings

EPS

Revenue

Revenue & Expenses

MTEM has released its 2024 Q2 earnings report, with revenue of 572.00K, reflecting a YoY change of -91.67%, and net profit of -8.10M, showing a YoY change of 25.50%. The Sankey diagram below clearly presents MTEM's revenue sources and cost distribution.

Key Indicators

Molecular Templates (MTEM) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Molecular Templates (MTEM)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Molecular Templates (MTEM)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Molecular Templates (MTEM)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown

Revenue Breakdown

Where does Molecular Templates (MTEM) generate its revenue? Explore its key revenue streams and top earning regions.

By Business

Data source:

By Region

Data source:

Dividend

Track Molecular Templates (MTEM) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History

Payout Ratio

Dividend Yield

You can ask Aime

No Data